Abbvie Inc [ABBV] stock is trading at $189.65, up 0.94%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ABBV shares have gain 0.57% over the last week, with a monthly amount drifted -0.84%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Abbvie Inc [NYSE: ABBV] stock has seen the most recent analyst activity on October 17, 2024, when Bernstein initiated its Mkt Perform rating and assigned the stock a price target of $203. Previously, HSBC Securities upgraded its rating to Buy on June 05, 2024, and kept the price target unchanged to $185. On May 17, 2024, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $200 on the stock. William Blair upgraded its rating to a Outperform. HSBC Securities downgraded its rating to a Hold. Goldman upgraded its rating to Buy for this stock on December 11, 2023. In a note dated November 09, 2023, Deutsche Bank initiated an Hold rating and provided a target price of $150 on this stock.
Abbvie Inc [ABBV] stock has fluctuated between $135.85 and $199.95 over the past year. Currently, Wall Street analysts expect the stock to reach $170.33 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $189.65 at the most recent close of the market. An investor can expect a potential drop of -10.19% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
Abbvie Inc [NYSE:ABBV] reported sales of 55.00B for the trailing twelve months, which represents a growth of 4.31%. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at 0.27%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.57 and Total Capital is 0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 10.42.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 188.39 points at the first support level, and at 187.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 190.69, and for the 2nd resistance point, it is at 191.73.
Ratios To Look Out For
For context, Abbvie Inc’s Current Ratio is 0.81. In addition, the Quick Ratio stands at 0.71 and the Cash Ratio stands at 0.31. Considering the valuation of this stock, the price to sales ratio is 6.09, the price to book ratio is 49.41 and price to earnings (TTM) ratio is 63.43.
Transactions by insiders
Recent insider trading involved Hudson Thomas J, Officer, that happened on Aug 08 ’24 when 49170.0 shares were purchased. EXECUTIVE CHAIRMAN OF BOARD, GONZALEZ RICHARD A completed a deal on Aug 05 ’24 to sell 66500.0 shares. Meanwhile, Officer Hudson Thomas J bought 0.1 million shares on Aug 07 ’24.
